IL10 and periodontitis: These data demonstrated that IL‐10‐MSCs treatment significantly enhanced the M2 activation of macrophages at the lesion site when compared to control and MSCs treatment, implying this is one potential mechanism underlying the superior treatment effects of IL‐10‐MSCs against periodontitis.